JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
Scope & Guideline
Advancing cardiovascular health through innovative pharmacology.
Introduction
Aims and Scopes
- Cardiovascular Drug Development:
The journal publishes studies investigating new pharmacological agents and their mechanisms of action in treating cardiovascular diseases, highlighting advancements in drug development. - Clinical Pharmacology and Therapeutics:
Research on the clinical application of cardiovascular drugs, including efficacy, safety, and pharmacokinetics, is central to the journal's scope. - Mechanisms of Cardiovascular Disease:
The journal explores the underlying biological mechanisms of cardiovascular diseases, providing insights into how various drugs can modify these pathways. - Personalized Medicine and Pharmacogenetics:
A focus on tailoring cardiovascular treatments based on genetic and phenotypic patient characteristics to optimize therapeutic outcomes. - Emerging Therapies and Innovations:
The publication highlights novel therapeutic approaches, including the use of biologics, gene therapy, and advanced drug delivery systems in cardiovascular care. - Interventional Cardiology:
Research on pharmacologic strategies during interventional procedures such as angioplasty and stenting, particularly concerning antiplatelet therapy and anticoagulation. - Cardiovascular Safety and Risk Management:
Studies addressing the safety profiles of cardiovascular drugs, including adverse effects, drug interactions, and risk factors associated with their use.
Trending and Emerging
- Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors:
Research on SGLT2 inhibitors has surged, emphasizing their role in heart failure management and cardiovascular protection beyond glucose control. - Antithrombotic Strategies and Dual Antiplatelet Therapy:
There is a growing emphasis on optimizing antithrombotic therapies, including novel approaches to dual antiplatelet therapy and their implications for various patient populations. - Biologics and Novel Therapeutics:
The journal increasingly features studies on biologics and new therapeutic modalities, reflecting a shift towards innovative treatment options in cardiovascular diseases. - Cardiovascular Outcomes in Diabetes Management:
Research on the cardiovascular implications of diabetes medications, particularly their effects on heart failure and other cardiovascular outcomes, is gaining prominence. - Regenerative Medicine and Stem Cell Therapy:
Emerging studies on the use of stem cells and regenerative medicine approaches to treat cardiovascular conditions are becoming a significant focus. - Pharmacogenomics in Cardiovascular Treatment:
The integration of pharmacogenomics into cardiovascular treatment strategies is increasingly prevalent, highlighting the importance of personalized medicine. - Impact of Inflammation on Cardiovascular Health:
Research exploring the role of inflammation in cardiovascular diseases and the potential therapeutic targets is trending, reflecting a growing understanding of pathophysiological mechanisms.
Declining or Waning
- Traditional Pharmacotherapies:
Research on established therapies, such as older anticoagulants and antiplatelet agents, appears to be waning as newer, more effective alternatives gain traction and clinical relevance. - Single-Agent Efficacy Studies:
There is a noticeable decline in studies focusing solely on the efficacy of single-agent therapies, as the field moves towards combination therapies and multi-target approaches. - Basic Science Studies Without Clinical Relevance:
Basic research studies that do not translate into clinical applications or implications are becoming less common, as the journal emphasizes translational research that impacts patient care. - Longitudinal Studies on Drug Safety:
Fewer longitudinal studies focusing on the long-term safety of cardiovascular drugs are being published, possibly due to a shift towards larger, multi-center trials that provide more comprehensive data.
Similar Journals
TRENDS IN CARDIOVASCULAR MEDICINE
Elevating Knowledge in Cardiovascular MedicineTRENDS IN CARDIOVASCULAR MEDICINE, published by Elsevier Science London, stands at the forefront of the cardiology field, with a commendable Q1 ranking in the category of Cardiology and Cardiovascular Medicine. Since its inception in 1991, this esteemed journal has provided a vital platform for disseminating cutting-edge research and innovative clinical practices, reflecting the dynamic developments in cardiovascular health. With an impact factor positioning it among the top 3% in its category, TRENDS IN CARDIOVASCULAR MEDICINE is essential reading for researchers, healthcare professionals, and students pursuing the latest advancements and evidence-based approaches in cardiology. Although this journal does not currently operate under an open-access model, its rich array of content encompasses a variety of topics from clinical studies to reviews, ensuring readers stay informed on the pivotal trends that shape cardiovascular medicine. This commitment to excellence underscores the journal's role as a premier resource for anyone dedicated to improving cardiovascular health.
BRITISH JOURNAL OF PHARMACOLOGY
Advancing pharmacological science for a healthier tomorrow.British Journal of Pharmacology is a premier, peer-reviewed journal published by Wiley, specializing in the dynamic field of pharmacology. With a robust impact factor, this journal ranks in the top quartile (Q1) for pharmacology according to the 2023 category rankings, emphasizing its significance and reputation among the global scientific community. As an essential resource for researchers, professionals, and students alike, the journal provides a platform for innovative research spanning foundational studies to clinical applications in pharmacology, toxicology, and pharmaceutics. Since its inception in 1966, the journal has consistently contributed to the advancement of pharmacological science, fostering a deeper understanding of drug action mechanisms and therapeutic advancements. Although primarily subscription-based, the British Journal of Pharmacology is committed to disseminating high-quality research that shapes the future of the field.
Anatolian Journal of Cardiology
Exploring Innovative Pathways in Cardiovascular Medicine.The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.
Journal of the Practice of Cardiovascular Sciences
Elevating Standards in Cardiovascular Research and PracticeJournal of the Practice of Cardiovascular Sciences, published by Wolters Kluwer Medknow Publications, is an esteemed Open Access journal dedicated to advancing knowledge in the field of cardiovascular health. With its ISSN 2395-5414 and E-ISSN 2454-2830, the journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality studies, innovations, and practical applications related to cardiovascular sciences. Established in 2015 as an Open Access journal, it promotes widespread sharing of insights to enhance cardiovascular practices and address contemporary challenges in the field. As part of a reputable publishing group, the journal is poised for growth and impact, contributing significantly to the ongoing dialogue in cardiovascular research and clinical practice.
Cardiology in Review
Advancing cardiovascular knowledge for a healthier tomorrow.Cardiology in Review, published by Lippincott Williams & Wilkins, is a prominent journal focused on advancing the field of cardiology and cardiovascular medicine. With a history of publication spanning from 1995 to 2024, the journal serves as an essential resource for researchers, healthcare professionals, and students alike, offering in-depth reviews and analyses on the latest developments, clinical practices, and research findings in cardiology. Despite being a traditional print journal, it maintains a commendable Q2 ranking in both cardiology and miscellaneous medicine categories as of 2023, reflecting its influence and rigor in the academic community, with a Scopus rank of #132 out of 387 in its field, placing it in the 66th percentile. The journal aims to bridge the gap between clinical practice and emerging research, promoting a deeper understanding and integration of innovative strategies in cardiovascular care. With its commitment to high-quality scholarship, Cardiology in Review remains a vital conduit for knowledge and dialogue within the evolving landscape of cardiovascular health.
Acta Cardiologica Sinica
Empowering the Global Cardiovascular Community.Acta Cardiologica Sinica is a distinguished journal dedicated to the advancement of cardiology and cardiovascular medicine, published by the Taiwan Society of Cardiology. Since its inception in 1988, this journal has provided a platform for researchers and clinicians to share cutting-edge findings and insights into cardiac health, cardiovascular diseases, and innovative treatment strategies. With an impressive Q3 classification in the Cardiology category for 2023, the journal is recognized for its contributions to the field, ranked #208 out of 387 in Scopus, placing it within the 46th percentile of medical journals. Although it currently does not offer open access options, it remains a valued resource for the global cardiovascular community. The journal's commitment to disseminating high-quality research papers, reviews, and case studies ensures that it plays a vital role in improving cardiovascular health practices and outcomes. For researchers, professionals, and students alike, Acta Cardiologica Sinica is essential reading for staying informed about the latest developments in cardiology.
PROGRESS IN CARDIOVASCULAR DISEASES
Driving Progress in Cardiovascular SciencePROGRESS IN CARDIOVASCULAR DISEASES is a leading journal in the field of cardiology and cardiovascular medicine, published by W B SAUNDERS CO-ELSEVIER INC. With an impressive impact factor that places it in the esteemed Q1 quartile of its category, this journal ranks among the top 32 out of 387 journals in its field, positioning itself in the 91st percentile. Since its inception in 1958 and continuing until 2024, it has been a prolific source of cutting-edge research, reviews, and clinical insights that contribute significantly to the understanding and treatment of cardiovascular diseases. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that all published content meets the highest standards of scientific excellence. As a key resource for researchers, practitioners, and students alike, PROGRESS IN CARDIOVASCULAR DISEASES serves as an indispensable tool for advancing knowledge and practice in cardiovascular health.
Giornale Italiano di Cardiologia
Innovating Cardiac Care Through Rigorous ResearchGiornale Italiano di Cardiologia is a premier journal in the field of cardiology, published by PENSIERO SCIENTIFICO EDITORE. Established in 1996, this journal serves as an essential platform for sharing the latest research and clinical advancements in cardiovascular medicine, particularly catering to the Italian and international medical communities. Although currently classified in the Q4 quartile for Cardiology and Cardiovascular Medicine (2023), the journal strives to enhance its impact and outreach by embracing rigorous peer-review practices and promoting high-quality submissions. With a commitment to enriching knowledge and fostering dialogue among researchers, clinicians, and students, the journal offers a collection of articles that include original research, reviews, and case studies. While currently not an Open Access publication, readers will benefit from a wealth of research insights that contribute to advancements in cardiac care and treatment strategies. As the Giornale Italiano di Cardiologia continues to evolve, it plays a vital role in bridging research and clinical practice in the cardiovascular domain.
AMERICAN JOURNAL OF CARDIOLOGY
Empowering Healthcare Professionals with Cutting-edge InsightsThe American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.
European Journal of Preventive Cardiology
Transforming the future of heart health through research.The European Journal of Preventive Cardiology, published by Oxford University Press, is a leading international journal dedicated to the field of cardiology and cardiovascular medicine. With an impact factor that underscores its prestige—ranking in the top quartile (Q1) of both cardiology and epidemiology categories—the journal serves as a critical resource for researchers and practitioners seeking to advance their understanding of preventive strategies in cardiovascular health. Since its inception in 1999, it has provided a platform for high-quality research and reviews that address the epidemiology of cardiovascular diseases, risk factor management, and innovative prevention methodologies. Notably, it currently ranks #21 out of 387 in Medicine - Cardiology and #13 out of 148 in Medicine - Epidemiology according to Scopus, highlighting its influential position in these essential biomedical fields. The journal also provides open access options, allowing both readers and authors the opportunity to engage with groundbreaking research and enhance the dissemination of knowledge. With a commitment to excellence, the European Journal of Preventive Cardiology is an invaluable asset for those dedicated to the prevention of cardiovascular diseases.